thymoquinone has been researched along with phorbolol myristate acetate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohno, S; Kumar, S; Linn, P; Nagatani, N; Soga, T; Takahashi, C; Watanabe, Y | 1 |
1 other study(ies) available for thymoquinone and phorbolol myristate acetate
| Article | Year |
|---|---|
Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion.
Topics: Animals; Apoptosis; Benzoquinones; Cell Line, Tumor; Gene Deletion; HEK293 Cells; Humans; Male; Mice, Knockout; Mice, Nude; Mice, SCID; PC-3 Cells; Prostatic Neoplasms; Retinoblastoma Protein; Succinate-CoA Ligases; Tetradecanoylphorbol Acetate | 2020 |